FORWARD FEATURES CALENDAR

Managers

Cirque Energy has entered into a USD5 million common stock purchase agreement with Kodiak Capital Group, a Newport Beach, California-based institutional investor. Cirque has agreed to file a registration statement with the US Securities and Exchange Commission covering the shares that may be issued to Kodiak under the terms of the common stock purchase agreement.   After the SEC has declared the registration statement related to the transaction effective, Cirque will have the right at its sole discretion over a period of one year to sell up to USD5 million of common stock under the terms set forth in the
Carne Group has received authorisation for an independent AIFMD-compliant management company in the Channel Islands. The new management company has become immediately operational with Carne Group’s fund clients. It is particularly suitable for alternative fund managers, including credit, hedge fund, private equity, infrastructure and real estate investment firms.   Carne has received authorisation as a fund services business from the Jersey regulator, the Jersey Financial Services Commission (JFSC).   Carne already has over 20 clients making use of its AIFMD management company solutions in Ireland and Luxembourg. The Jersey management company is the first to be approved outside the European
Advent Life Sciences has closed its Advent Life Sciences Fund II (ALSF II), a GBP145.5 million (USD235 million) venture capital fund raised to seed and build life sciences companies in the UK, Europe and the US. The fund will back entrepreneurs and early-stage and mid-stage companies with the potential to deliver first- or best-in-class breakthrough products for unmet medical needs.   The fund, which quickly exceeded its target, was raised entirely from independent financial investors including funds-of-funds, pension funds, and family offices.   “We thank our returning and new LPs for the strength of their support, which allowed us to
Infracapital, the infrastructure investment arm of M&G Investments and parent Prudential plc, has reached a final closing of its latest fund, Infracapital Partners II, with total commitments of GBP1.0 billion (USD1.6 billion). Co-investment pledges take the total investable funds to over GBP1.3 billion. As with its predecessor, Infracapital Partners LP, the fund’s strategy is to invest in, and actively manage, core infrastructure assets across Europe.   The fundraising, which exceeded its initial target, received strong backing from existing investors and in addition welcomed a number of new investors from across Europe, North America and Asia.  In addition to seed capital
Private equity firm GTCR is to sell portfolio company Devicor Medical Products to Danaher Corporation’s Leica Biosystems, a provider of anatomical pathology solutions and automation used to advance cancer diagnostics. Devicor is a medical device company specialising in products for use in breast biopsy procedures. The company is the global market leader in the vacuum-assisted biopsy segment of the breast biopsy market. Its products include the Mammotome Breast Biopsy System, tissue markers and related products, which, to date, have enabled more than four million women to have a minimally invasive breast biopsy.   Devicor began as a management partnership formed
British pounds
IMSPEX Diagnostics Limited has completed its GBP1.4 million funding round led by Finance Wales and the Angel CoFund. The funds will be invested in establishing a group administration and sales team who will be based in Abercynon.   IMSPEX acquired Dortmund based technology company G.A.S GmbH in January 2013. The subsidiary develops and manufactures the group’s range of analytical instrumentation based on Ion Mobility Spectrometry (IMS).  The lead products are the Siloxane and Beer analysers.  The Siloxane device monitors the quality of biogas in real time, ensuring it is sufficiently clean to pump on to national gas grids.  The beer analyser
Private equity firm Warburg Pincus has closed Warburg Pincus Energy at USD4 billion, surpassing its fundraising target of USD3 billion and reaching the fund cap agreed with investors.  Warburg Pincus Energy will be a companion fund to Warburg Pincus Private Equity XI, a USD11.2 billion global private equity fund, which closed in May 2013.  Warburg Pincus Energy was launched in November 2013 and held an oversubscribed first close in May 2014.   Warburg Pincus Energy will focus primarily on energy exploration and production (E&P) investing in North America and across the globe including Africa, Asia, Europe and Latin America. In addition
Marwyn Value Investors has entered into a placing letter to subscribe for GBP8.96 million of new ordinary shares in Haversham Holdings plc. Haversham intends to float on AIM, a London Stock Exchange market. This investment represents approximately 4.8 per cent of the NAV of the company’s ordinary shares (measured as at 17 October 2014).   Haversham is a group formed by Avril Palmer-Baunack and Marwyn with the support of leading institutional investors, including Invesco, Artemis, Aviva and Schroders. It acquires and develops businesses in the UK and European automotive, support services, leasing, engineering or manufacturing sectors, targeting acquisitions with an
Private equity firm Arlington Capital Partners has acquired the Zemax division of Radiant Zemax, a provider of optical and illumination design software to design engineers. Zemax becomes the sixth company with licensable software in Arlington Capital's current portfolio, joining Advanced Health, Compusearch, Iron Data, Novetta, and Quantum Spatial.   Zemax’s OpticStudio software platform allows users to design, tolerance and simulate sophisticated optical or illumination systems. The company’s installed base spans across 80 different countries and includes over 7,500 different companies, including global industry leaders in aerospace, defence, medical/life sciences, technology, and leading research and development units within the government.  
Euros
Assets under management of Luxembourg domiciled funds reached EUR3,006.76 billion at the end of September 2014. This represents a 14.97 per cent increase since the beginning of this year and is mainly due to net sales.   Marc Saluzzi, chairman of the Association of the Luxembourg Funds Industry (ALFI), says: “Assets under management have steadily increased since September 2013, and whilst with volatile markets assets under management actually may drop, it is encouraging both that investors have confidence in investment funds generally and that fund promoters continue to choose Luxembourg as a domicile.    “Luxembourg remains the most prominent international

Events

12 November, 2026 – 8:00 am

Directory Listings